Trials / Unknown
UnknownNCT05330507
Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions
POWER: Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Convexity Scientific Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective, observational study is designed to investigate clinical outcomes and collect patient feedback on the use of Wellinks, an integrated virtual chronic obstructive pulmonary disease (COPD) management solution, for patients recently discharged from the hospital due to an acute exacerbation of their COPD.
Detailed description
Wellinks, an integrated virtual COPD management solution consists of a combination of health coaching, Bluetooth-connected devices, collection of patient-reported symptoms and medication use, and virtual pulmonary rehabilitation, all centralized by the use of a mobile-phone application (mobile app) downloaded onto a study participant's iOS (iPhone) or Android device. The clinical objectives of this study are to determine whether utilization of Wellinks can reduce the rate of hospital readmissions due to a COPD exacerbation for patients recently discharged from the hospital. The nonclinical objectives of this study are to describe the experience of study participants using Wellinks through the assessment of engagement with the components of Wellinks, as well as by participant-reported satisfaction and perceived value (e.g., willingness to pay). Qualitative feedback on the features and functionality of Wellinks will be solicited.
Conditions
- COPD
- Respiratory Tract Disease
- Pulmonary Disease, Chronic Obstructive
- Lung Diseases, Obstructive
- Lung Diseases
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Wellinks | 30-day post-discharge period: virtual respiratory therapist sessions twice per week with synchronous virtual pulmonary rehabilitation and educational materials; at-home use of connected spirometer and pulse oximeter; at-home use of mobile app. 12-week intensive period: virtual health coaching sessions once every two weeks; asynchronous virtual pulmonary rehabilitation program; ongoing access to connected devices (spirometer and pulse oximeter) and mobile app. |
Timeline
- Start date
- 2022-07-05
- Primary completion
- 2024-06-01
- Completion
- 2024-06-01
- First posted
- 2022-04-15
- Last updated
- 2023-11-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05330507. Inclusion in this directory is not an endorsement.